Back

Is HBA1C reliable in diagnosing diabetes in the acute phase of acute coronary syndromes?

13 March 2021 (08:30 - 23:59)
Organised by:
Congress Presentation Part of: ePoster session Lifestyle Modification ACVC Premium Access ACVC 2021

About the speaker

Photo
Doctor Maria Stratinaki

Venizelio General Hospital, Heraklion (Greece)

153 More presentations in this session

Presentation thumbnail
Budget impact analysis of antiplatelet therapy with cangrelor in patients with acute coronary artery disease undergoing percutaneous coronary intervention in Portugal
Doctor I. Lizano-Diez (Barcelona, ES)
Abstract
Presentation thumbnail
Budget impact analysis of antiplatelet therapy with cangrelor in patients with acute coronary artery disease undergoing percutaneous coronary intervention in Belgium
Doctor I. Lizano-Diez (Barcelona, ES)
Abstract
Presentation thumbnail
The clinical significance of blood lactate levels in evaluation of adult patients with Veno-Arterial Extracorporeal Membrane Oxygenation .
Assistant Professor M. Laimoud (Riyadh, SA)
Abstract
Presentation thumbnail
Implantable loop recorder: experience of a center
Doctor C. Marques Pires (Braga, PT)
Abstract
Presentation thumbnail
Bleeding predictors in acute coronary syndrome: does the age or clinical presentation matters?
Doctor C. Marques Pires (Braga, PT)
Abstract

Access the full session

Session thumbnail
ePoster session

The Event

Event poster

ACVC 2021

13 March 2021 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Newly diagnosed diabetes at acute myocardial infarction presentation: higher glycemic burden, more multivessel-disease but similar clinical severity to non-diabetics
20 March 2026
thumbnail
Congress Presentation
C-reactive protein in addition to GRACE Score improves risk stratification in acute coronary syndrome
22 May 2023
thumbnail
Congress Presentation
Does prediabetes diagnosed by hemoglobinA1c or oral glucose tolerance test predict coronary artery disease in patients suspected of chronic coronary syndrome?
26 August 2023
thumbnail
Congress Presentation
Validation of Electrocardiographic Recording in Smartwatches for the Diagnosis of Non-ST-Segment Elevation Acute Coronary Syndrome. Preliminary Analysis of the ACS WATCH II
14 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources